Do you want to read an article? Please log in or register.
Treating heart failure patients with anti-obesity medication reduces greenhouse gas emissions and improves clinical outcomes
Heart Failure
ESC 2025
Related content
Heart Failure
Effects of dapagliflozin on blood volume status and vascular outcomes in clinically stabilized heart failure patients after an acute decompensated heart failure event (DAPA-VOLVO study): Protocol of a double-blind randomized controlled clinical trial
PLoS One
Bitos K, Laptseva N, Haider T, Rossi VA, Nägele MP, Barthelmes J, Ruschitzka F, Sudano I, Flammer AJ
doi: 10.1371/journal.pone.0325668
Heart Failure
Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure With Improved Ejection Fraction
J Am Coll Cardiol
Min KH, Go AS, Lee K, Parikh RV, Horiuchi KM, Ambrosy AP, Tan TC, Srikanth K, Hamilton SA, Svetlichnaya J, Solomon SD, Inciardi RM, Vardeny O, Vasti E, Sandhu AT, Ku IA, Adatya S, Bhatt AS
doi: 10.1016/j.jacc.2025.05.040
Heart Failure
Implementation of guideline-recommended therapies in heart failure with reduced ejection fraction according to heart failure duration: An analysis of 55 581 patients from the Swedish Heart Failure (SwedeHF) Registry
Eur J Heart Fail
Shahim A, Linde C, Savarese G, Dahlström U, Lund LH, Hage C
doi: 10.1002/ejhf.3565
Heart Failure
Implementation of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction (OpTIMa-HF Registry)
ESC Heart Fail
Paolillo S, Basile C, Marzano F, Bruzzese D, Agostoni P, Mattavelli I, Aloisio A, Ameri P, Solimano M, Brunetti ND, Calabrò P, Cesaro A, Cameli M, Mandoli GE, Carluccio E, Belardinelli C, Carugo S, Casalino L, Chiuini E, Cosmi D, Dini FL, Di Santo M, Esposito G, Ferrara F, Fierro MF, Galasso G, Gallo L, Rispoli A, Gargiulo P, Grigioni F, Segreti A, Guarnaccia F, Guarnaccia N, Guerra F, Cicchirillo E, Indolfi C, Larcher M, Lillo A, Metra M, Montisci R, Marchetti MF, Nodari S, Fioretti F, Nardi E, Oliviero U, Palazzuoli A, Patti G, Pepe M, Pacelli F, Perrone Filardi F, Putortì G, Santoro G, Senni M, D'Elia E, Severino P, D'Amato A, Soriano S, Sinagra G, Rossi M, Franzese M, Smaldone G, Zito GB, Perrone Filardi P
doi: 10.1002/ehf2.15172
Heart Failure
Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure
Circulation
Berg DD, Patel SM, Haller PM, Cange AL, Palazzolo MG, Bellavia A, Kuder JF, Desai AS, Inzucchi SE, McMurray JJV, O'Meara E, Verma S, Bělohlávek J, Drożdż J, Merkely B, Ogunniyi MO, Drasnar T, Izzo JL, Sarman B, McGinty JE, Ramanathan K, Mulkay AJ, Przybylski A, Ruff CT, O'Donoghue ML, Murphy SA, Sabatine MS, Wiviott SD, DAPA ACT HF-TIMI 68 Trial Committees and Investigators
doi: 10.1161/CIRCULATIONAHA.125.076575
COMMENTED
Heart Failure
Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA(1c) levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trial
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Lancet Diabetes Endocrinol
Davies MJ, van der Meer P, Verma S, Patel S, Chinnakondepalli KM, Borlaug BA, Butler J, Kitzman DW, Shah SJ, Harring S, Salsali A, Rasmussen S, von Lewinski D, Abhayaratna W, Petrie MC, Kosiborod MN, STEP-HFpEF Trials Committees and Investigators
doi: 10.1016/S2213-8587(24)00304-8
Heart Failure
Characteristics and outcomes of patients with heart failure and history of malignancy: Data from Swedish Heart Failure Registry and the National Cancer Register
Eur J Heart Fail
Ameri P, Costa P, Benson L, Stolfo D, Sayour NV, Ljungman C, Butler J, Anker SD, Girerd N, Keramida K, Filippatos G, Lund LH, Lindberg F, Savarese G
doi: 10.1002/ejhf.3775
Heart Failure
Guideline-directed medical therapy rates in heart failure patients with reduced ejection fraction in a diverse cohort
ESC Heart Fail
Berry NC, Sheu YS, Chesbrough K, Bishop RC, Vupputuri S
doi: 10.1002/ehf2.15193
Heart Failure
Temporal Changes in Biomarkers, Functional Status, and Quality of Life Prior to Adverse Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
JACC Heart Fail
Lu H, Claggett BL, Vaduganathan M, Desai AS, Jhund PS, Voors AA, Senni M, Zannad F, Pitt B, Shah SJ, Lam CSP, Scheerer MF, Scalise A, Mueller K, Berger M, Goea L, McMurray JJV, Solomon SD
doi: 10.1016/j.jchf.2025.102590